Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells

Avanish Mishra(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), Aditya Bardia(UCLA Health), Daniel A. Haber(Howard Hughes Medical Institute), Leif W. Ellisen(Harvard University), Jon F.(Massachusetts General Hospital), Kaustav A. Gopinathan(Harvard University), S Z Huang(Howard Hughes Medical Institute), Kruthika Kikkeri(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), Quinn Cunneely(Harvard University), Ke Xu(Biomechanics Institute of Valencia), Akansha Deshpande(Massachusetts General Hospital), J. Kelly(Massachusetts General Hospital), J. T. Walsh(Harvard University), J. T. A. Knape(Massachusetts General Hospital), Olivia Rieur(Massachusetts General Hospital), Elizabeth M. Seider(Center for Cancer Research), Linda Nieman(Massachusetts General Hospital), Victor Putaturo(Harvard University), Rachel O. Abelman(Massachusetts General Hospital), Mythreayi Shan(Massachusetts General Hospital), David T. Ting(Massachusetts General Hospital), Charles S. Dai(Massachusetts General Hospital), Remy Bell(Harvard University)
Proceedings of the National Academy of Sciences
June 17, 2026
Cited by 1


Related Papers